Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | CPA3 | P15088 | 3/20 | 0.48 |
| ▸ | CPA1 | P15085 | 2/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1573822 | 1.00 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL3724926 | 1.00 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL2238484 | 0.88 | MME (0.48) | CYP1A2CPA1FOLH1NPSR1 | |
| SCHEMBL2238482 | 0.88 | MME (0.48) | CYP1A2CPA1FOLH1NPSR1 | |
| SCHEMBL607090 | 0.85 | SLC7A5 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL607091 | 0.85 | SLC7A5 (0.55) | SLC7A5FOLH1 | |
| SCHEMBL11710892 | 0.82 | ADAMTS5 (0.50) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL31114841 | 0.82 | ADAMTS5 (0.50) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL2466759 | 0.82 | CYP1A2 (0.57) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL157789 | 0.82 | CYP1A2 (0.57) | CYP1A2ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117405800-A | Method for simultaneously detecting reduced biological ammonia sulfhydryl compound and oxidized biological ammonia sulfhydryl compound | 上海中医药大学 | 2024-01-16 | — | — | CN | claimed |
| CN-116678974-A | Screening method of Alzheimer disease plasma metabolism marker, plasma metabolism marker and application | 上海大学 | 2023-09-01 | — | — | CN | claimed |
| EP-3149029-B1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2019-06-19 | — | — | EP | claimed |
| EP-3094643-B1 | LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE | FYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY V V I (CZ) | 2018-10-17 | — | — | EP | claimed |
| CN-108026162-A | Cystine knot scaffold platform | 豪夫迈·罗氏有限公司 | 2018-05-11 | — | — | CN | claimed |
| EP-3157948-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2017-04-26 | — | — | EP | claimed |
| EP-3149029-A1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2017-04-05 | — | — | EP | claimed |
| US-20170051031-A1 | LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-02-23 | — | — | US | claimed |
| US-20170044230-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-02-16 | — | — | US | claimed |
| EP-3094643-A2 | LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE | Fyziologicky Ústav Akademie VED Ceské Republiky, V.V.I. (CZ) | 2016-11-23 | — | — | EP | claimed |
| WO-2004063212-A2 | ORGANIC COMPOUNDS WITH BIOLOGICAL ACTION AS THROMBIN INHIBITORS AND USE THEROF | CPI CREATIVE PHARMA INTERNATIONAL GMBH (DE) | 2004-07-29 | — | — | WO | claimed |
| EP-1425296-A1 | ORGANIC COMPOUNDS WITH BIOLOGICAL ACTIVITY AS THROMBIN INHIBITORS AND USE THEREOF | Novel Science International Gmbh (DE) | 2004-06-09 | — | — | EP | claimed |
| WO-2003022873-A1 | ORGANIC COMPOUNDS WITH BIOLOGICAL ACTIVITY AS THROMBIN INHIBITORS AND USE THEREOF | NOVEL SCIENCE INTERNATIONAL GMBH (DE) | 2003-03-20 | — | — | WO | claimed |
| EP-0938328-A4 | METHOD OF INHIBITING FIBROSIS WITH A SOMATOSTATIN AGONIST | BIOMEASURE INC (US) | 2002-08-28 | — | — | EP | claimed |
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | claimed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | claimed |
| EP-0938328-A1 | METHOD OF INHIBITING FIBROSIS WITH A SOMATOSTATIN AGONIST | Biomeasure Incorporated (US) | 1999-09-01 | — | — | EP | claimed |
| WO-1998008529-A1 | METHOD OF INHIBITING FIBROSIS WITH A SOMATOSTATIN AGONIST | BIOMEASURE INCORPORATED (US) | 1998-03-05 | — | — | WO | claimed |
| US-5352666-A | Using a renin inhibitor | SCHERING CORPORATION (US) | 1994-10-04 | — | — | US | claimed |
| EP-0395417-A1 | Linear somatostatin analogues | The Administrators of The Tulane Educational Fund (US) | 1990-10-31 | — | — | EP | claimed |